The Technical Analyst
Select Language :
Pieris Pharmaceuticals [PIRS]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Pieris Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals

Pieris Pharmaceuticals is listed at the  Exchange

-4.69% $0.185

America/New_York / 28 mar 2024 @ 15:33


Pieris Pharmaceuticals: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 18.24 mill
EPS: -0.340
P/E: -0.540
Earnings Date: Mar 28, 2024
SharesOutstanding: 98.85 mill
Avg Daily Volume: 0.592 mill
RATING 2024-03-28
B+
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Buy
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.540 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.09x
Company: PE -0.540 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.172 - 0.196

( +/- 6.51%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-06-21 Barbier Ann Buy 40 000 Stock Option (right to buy)
2023-06-21 Geraghty James A Buy 45 000 Stock Option (right to buy)
2023-06-21 Kiener Peter A Buy 40 000 Stock Option (right to buy)
2023-06-21 Kiritsy Christopher P Buy 40 000 Stock Option (right to buy)
2023-06-21 Richman Michael Buy 40 000 Stock Option (right to buy)
INSIDER POWER
18.41
Last 97 transactions
Buy: 6 636 987 | Sell: 4 508 050

Forecast: 16:00 - $0.185

Live Trading Signals (every 1 min)

Forecast 1: 15:42 - $0.185
Forecast 2: 16:00 - $0.185
Forecast 3: 16:00 - $0.185
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.185 (-4.69% )
Volume 0.360 mill
Avg. Vol. 0.592 mill
% of Avg. Vol 60.78 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Pieris Pharmaceuticals Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Pieris Pharmaceuticals Inc

RSI

Intraday RSI14 chart for Pieris Pharmaceuticals Inc

Last 10 Buy & Sell Signals For PIRS

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Pieris Pharmaceuticals Inc

PIRS

Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in human blood plasma and other bodily fluids. Its lead respiratory Anticalin-based drug candidate includes PRS-060/AZD1402, a drug candidate that is in Phase II clinical trial targeting IL-4Ra for the treatment of asthma and other inflammatory diseases; PRS-220, an oral inhaled Anticalin protein targeting connective tissue growth factor for the treatment of idiopathic pulmonary fibrosis; and immune-oncology program comprises Cinrebafusp alfa, a 4-1BB/ HER2 bispecific for the treatment of HER2-high and HER2-low expressing gastric cancers. The company also develops PRS-344/S095012, a bispecific anticalin-antibody fusion protein targeting 4- 1BB and PD-L1 for immuno-oncology diseases that is in phase 1 clinical trial; and PRS-352, a preclinical-stage program addressing undisclosed targets for immuno-oncology diseases. It has a license and collaboration agreement with Les Laboratoires Servier and Institut de Recherches Internationales Servier, AstraZeneca AB, and Seagen Inc.; and license agreements with Technical University of Munich, Enumeral Biomedical Holdings, Inc., and Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. The company also has a clinical trial collaboration and supply agreement with Eli Lilly and Company. Pieris Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Boston, Massachusetts.

Last 10 Buy Signals

Date Signal @
KRYSMar 28 - 15:32$177.33
ULTAMar 28 - 15:31$523.00
TGTXMar 28 - 15:32$15.31
WTAOUSDMar 28 - 15:28547.49
NBIXMar 28 - 15:30$137.23
PHBUSDMar 28 - 15:252.75
PFFMar 28 - 15:25$32.34
CRSPMar 28 - 15:23$68.01
CVCUSDMar 28 - 15:23$0.217
IBKRMar 28 - 15:20$112.04

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.